Skip to main content

Purpose & Achievements

Fighting Cancer

At the Weizmann Institute of Science, more than 50 research groups focus on developing better ways to prevent, diagnose, and treat cancer. In fact, nearly half of Weizmann’s life sciences research is cancer-related. Institute research has provided critical knowledge about cancer in general – Weizmann scientists were the first to demonstrate that cancer can grow in stages – as well as about specific cancers, such as breast, lung, and prostate. The Institute’s collaborative teams are working to turn basic research into powerful diagnostic tools, drugs, and therapies to fight cancer – and win.

Weizmann by the numbers

We were first to clone p53, the gene involved in over 50% of all cancers

Prof. Hadassa Degani developed an MRI-based method called three time point (3TP) that identifies cancer without the need for painful biopsies. It is FDA approved for diagnosing breast and prostate cancer.

Our research led to the world’s first bone-marrow transplant between incompatible people

Over 60 research groups focus on cancer – that’s ~40% of all our life-science research


    Cancer alters cellular waste-processing machinery, helping it avoid detection by the immune system
    Weizmann Institute researchers identify a biomarker that may one day enable a subgroup of lung cancer patients to benefit from relapse-free treatment
    Wasting syndrome – a deadly cancer side-effect – might be diagnosed and treated early on, according to a new study
    If larger studies confirm the results of a Weizmann Institute innovation, diagnosing cancer may one day be as easy as taking blood
    How tumors mutate their way out of a crisis – and become drug resistant in the process
    Natural antibodies found in tumors could point the way toward improved immunotherapy
    A gene for transport helps aggressive cancer cells move and spread
    A particularly “sticky” molecule could lead to the development of an effective treatment for cancer
    Prof. Victor Malka’s laser research is a beam of hope for future cancer treatment